Multiple System Atrophy – perspectives in diagnosis?
Objective: The aim of this study was to study the role of perfusion single photon emission computed tomography (SPECT) in the examination of multiple system…Parkinsonism in HIV positive persons in South Africa
Objective: To describe the clinical features of Persons living with HIV (PLH) with Parkinson's disease Background: Parkinson’s disease is a disease of ageing(1) . As…A possible case of prodromal DLB with prominent hallucinations, autonomic dysfunction, and REM behavior disorder but absence of cognitive impairment
Objective: Dementia with Lewy bodies (DLB) is the second most common cause of neurodegenerative dementia, after Alzheimer’s disease (AD). While mild cognitive impairment (MCI) is…Clinical heterogeneity and neuropathological correlation in progressive supranuclear palsy – description of 4 cases
Objective: Description of four cases of definite PSP and assessment of the relation between clinical characteristics and severity and topographical distribution of tau pathology pathology.…An outlook: Palliative care for patients with Parkinsonism syndrome
Objective: The main purpose of study is to provide interventions and highlight the assessment of supportive care needs in Parkinson’s disease. Background: A clinical syndrome…Identifying perceptual, motor and cognitive components contributing to the slowness of information processing in Parkinson’s disease and the implication in the quality of life
Objective: To identify, through tasks of reaction times (RT), the motor, cognitive and perceptual components involved in the processing of information in PD and to…A genome wide pleiotropic approach to identify the genetic architecture of multiple system atrophy and its interaction with Parkinson’s disease
Objective: The aim of this study is to provide new insights into the genetic architecture of multiple system atrophy (MSA) and investigate shared molecular genetic…Improving outcomes in hospitalized Parkinson’s patients
Objective: Evaluate an inpatient intervention to reduce rates of hospital related complications in hospitalized patients with Parkinson’s disease (PD). Background: Several interventions have been suggested…Limitations of Curcumin as a Therapeutic Agent in Rotenone Induced Dopaminergic Neurodegeneration: Insights from Drosophila Model of Parkinson’s Disease
Objective: To understand the efficacy of curcumin in rotenone induced Drosophila model of Parkinson’s disease. Background: Parkinson’s disease (PD) is the second most common neurodegenerative…Three-year follow-up of a patient with a rare combination of taupathy (PSP) and synucleopathy (MSA)
Objective: We couldn't find an article showing that MSA and PSP appeared simultaneously in the same patient in the english literature. We wanted to present…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.